Paula Kostuik Neidhard
Acute Care · Montgomery, OHNPI 1518909415
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,263 of the $1,497 with a category attached, or 84.4%. It is spread thinly across 24 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,206, 5.3 times the $228 reported in 2022.
Across 60 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$202
- Novartis$156
- Genentech USA, Inc.$139
- Lilly USA, LLC$110
- Seagen Inc.$99
- Pfizer$98
- plus $694 from 18 others
What the payments were for
- Food & beverage$1,26384%
- Education$23316%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 9 | $202 |
| Novartis | 7 | $156 |
| Genentech USA, Inc. | 2 | $139 |
| Lilly USA, LLC | 1 | $110 |
| Seagen Inc. | 1 | $99 |
| Pfizer | 5 | $98 |
| Bayer | 4 | $86 |
| Daiichi Sankyo Inc. | 5 | $84 |
| Merck | 3 | $69 |
| Astellas Pharma US Inc | 4 | $66 |
| Bristol Myers Squibb | 3 | $59 |
| AstraZeneca(2 entities) | 2 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| AbbVie | 1 | $32 |
| Incyte Corporation | 1 | $26 |
| Beone Medicines USA, Inc. | 1 | $22 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Sobi, Inc | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| GSK | 1 | $17 |
| Sanofi | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Novocure Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclexta$118
How this compares
$1,497 in reported general payments places this provider in the 80th percentile of 1,101 acute care providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levofloxacin | 11 | $118 |
Paid to pharmacies, not to this prescriber.
Other acute care in Montgomery
- Lindsay ThobeMontgomery$7K
- Chelsea PolleysMontgomery$5K
- Andrea RobinsonCleveland$149K
- Brittney BrowneMonroe$142K
- Jamie McGuireMiamisburg$86K
- Ileah ReichertColumbus$73K
- Davida PraterBeavercreek$46K
- Dawn FrenchAlliance$40K
- Holly McKibbenColumbus$23K
- Jody HussBlue Ash$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.